DekaBank Deutsche Girozentrale »

United Therapeutics Corporation shares owned by DekaBank Deutsche Girozentrale

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by DekaBank Deutsche Girozentrale from 13F filings

Historical chart of DekaBank Deutsche Girozentrale investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by DekaBank Deutsche Girozentrale consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by DekaBank Deutsche Girozentrale

Quarter filed Position value Share count Share price at filing
2013-03-31 $2.1M 35k 60.86
2012-12-31 $1.9M 36k 52.13
2012-09-30 $2.2M 39k 55.88
2012-06-30 $2.0M 41k 49.37
2012-03-31 $2.3M 48k 47.35
2011-12-31 $2.6M 55k 47.25
2011-09-30 $1.7M 45k 37.46
2011-06-30 $3.2M 58k 54.77
2011-03-31 $4.0M 60k 66.83

More positions owned by DekaBank Deutsche Girozentrale

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Merck & Co (MRK)
Accenture Plc Ireland Shs Class A (ACN)
Abbvie (ABBV)
Coca-Cola Company (KO)
UnitedHealth (UNH)

View all positions for DekaBank Deutsche Girozentrale

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation